Sangamo Therapeutics Inc (LTS:0R1D)
$ 2.18 -0.06 (-2.68%) Market Cap: 492.41 Mil Enterprise Value: 480.93 Mil PE Ratio: 0 PB Ratio: 12.55 GF Score: 41/100

Sangamo Therapeutics Inc Annual Shareholders Meeting Transcript

May 25, 2021 / 03:30PM GMT
Release Date Price: $10.84
Operator

Hello, and welcome to the 2021 Annual Stockholder Meeting of Sangamo Therapeutics. Please note that today's meeting is being recorded. During the meeting, we will have a question-and-answer session. Stockholders of record and registered beneficial owners who logged on to the meeting center with a control number can submit questions at any time by clicking on the message icon.

It is now my pleasure to turn today's meeting over to Sandy Macrae, President and Chief Executive Officer of Sangamo Therapeutics, who is serving as Chair of today's meeting. Dr. Macrae, the floor is yours.

Alexander D. Macrae
Sangamo Therapeutics, Inc. - CEO, President & Director

Good morning, everyone, and welcome to the 2021 Annual Stockholder Meeting of Sangamo Therapeutics. I'm the President and CEO of Sangamo Therapeutics, and I'm the Chair of today's meeting. Also present virtually is Gary Loeb, Sangamo's Executive Vice President and General Counsel, who is serving as the Secretary of the meeting. It is my pleasure, on behalf of Sangamo Therapeutics, its Board of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot